脑部放疗,上午比下午敏感许多!
6 O4 @) F+ u- Z- Z3 c. d) T3 h F! v$ {% S
6 M, O$ `- H: k' v, P& LCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.! R4 w- r3 {! J# f
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?/ S6 b# D0 i$ e+ g( w4 h8 \+ N
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T., S! S4 o9 \* c/ B' w. H
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
& b0 ^/ k5 J7 W9 o
5 d$ v) v; g- Y' _9 m" K2 [Abstract
J; y+ o" z$ A/ Z) K! G/ p! ^3 U* ~BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
% Y0 \% b$ H( ^5 B. E: h& Y
: O9 ~. U" \/ E$ f: I& E! h# }METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.0 h! Z7 {5 U1 Y
( p" z9 V+ ?4 W" A
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).0 R# I$ G$ Y4 R& ^; p$ N9 l) b
" h" p3 P+ i+ ?& ?& K5 YCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
8 D2 @- h: t6 P( H! ^% z- N2 `- Z2 y7 c6 T7 R
|